A very interesting as well as impressive discussion between Nobel Prize awardee, Prof. Tasuku Honjo, and BioNtech CEO Prof. Ugur Sahin.
From this discussion, we could learn the persistent efforts for cancer vaccine in tumor immunology has made the mRNA vaccine against SARS CoV2 achieved so quickly. Needless to mention of their relentless efforts Sahin called "light speed" project at his lab has made it as well.
Both of them sound very honest and open minded as for their research. Both of them have approved the open mindedness in the science community recently realized such as discussion through preprint papers.
Discovery of PD1 by Prof. Honjo was also epoch making. But he is not satisfied with it yet but is looking ahead for further collaborative study of anti PD1 with the other measures of treatment for cancer. Prof. Sahin is aware of the limited span of effectiveness of the vaccine for antibody production. They may elucidate how many boosters and the intervals of them are necessary soon. There are people who insist of the side effects of the vaccine. As Prof. Sahin says, the merit and demerit must be judged based on their balance. The balance seems to favor absolutely for the merit.
Human body, as they told in the concluding remark, is such a complicated system. It is also influenced by the environment etc. Single chemical molecule or single kind of cell won't solve the problem. Flexible and open minded attitude for research could do that in the future.
https://youtu.be/ysVaz4APGvw
No comments:
Post a Comment